Cargando…
Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 Mutation
Glioblastoma is the most fatal brain cancer found in humans. Patients suffering from glioblastoma have a dismal prognosis, with a median survival of 15 months. The tumor may develop rapidly de novo in older patients or through progression from anaplastic astrocytomas in younger patients if glioblast...
Autores principales: | Liu, Aizhen, Hou, Chunfeng, Chen, Hongfang, Zong, Xuan, Zong, Peijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731485/ https://www.ncbi.nlm.nih.gov/pubmed/26858939 http://dx.doi.org/10.3389/fonc.2016.00016 |
Ejemplares similares
-
Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
por: Haider, Ali S., et al.
Publicado: (2023) -
Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond
por: El Khayari, Abdellatif, et al.
Publicado: (2022) -
Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer
por: Guo, Jinxiu, et al.
Publicado: (2021) -
Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses
por: Liu, Yu-Qing, et al.
Publicado: (2019) -
The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation
por: Marchi, Francesco, et al.
Publicado: (2020)